Skip to content

Circadian Modulation of Grape Consumption and Oxidative Stress Response

Circadian Modulation of Grape Consumption and Oxidative Stress Response

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05873530
Enrollment
32
Registered
2023-05-24
Start date
2021-09-01
Completion date
2023-05-01
Last updated
2023-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oxidative Stress

Brief summary

This study investigated the effects of time-of-day of grape consumption on high-fat meal-induced oxidative stress.

Detailed description

Grape consumption acts on the immune system to produce antioxidant and anti-inflammatory effects. Since immune activity demonstrates circadian rhythmicity, with peak activity occurring during waking hours, the timing of grape intake may influence the magnitude of its antioxidant effect. This study followed a 2 x 2 factorial randomized, controlled design wherein healthy men and women (n = 32) consumed either a grape or placebo drink with a high-fat meal in the morning or evening. Urine was collected for measurements of biomarkers of oxidative stress and grape metabolites at baseline and post-meal at hour 1 and hours 1-6

Interventions

OTHERGrape

Reconstituted whole grape powder

Sponsors

Idaho State University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy * Age 18-50 y

Exclusion criteria

* Employed in shift or night work * Extreme early or late chronotype * Presence of acute infection or chronic inflammatory disease * Smoking * Heavy aerobic exerciser * Greater than moderate alcohol intake * Pregnancy or lactation * Use of non-steroidal anti-inflammatory medications or antioxidant dietary supplements.

Design outcomes

Primary

MeasureTime frameDescription
Urine F2-isoprostanebaselineOxidative stress marker

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026